Literature DB >> 361228

Phase II evaluation of pyrazofurin in patients with metastatic sarcoma.

R J Gralla, P P Sordillo, G B Magill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 361228

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

Review 1.  The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities.

Authors:  Paz Nombela; Borja Miguel-López; Sandra Blanco
Journal:  Mol Cancer       Date:  2021-01-18       Impact factor: 27.401

2.  Dynamics of subgenomic hepatitis C virus replicon RNA levels in Huh-7 cells after exposure to nucleoside antimetabolites.

Authors:  Lieven J Stuyver; Tamara R McBrayer; Phillip M Tharnish; Abdalla E A Hassan; Chung K Chu; Krzysztof W Pankiewicz; Kyochi A Watanabe; Raymond F Schinazi; Michael J Otto
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

3.  Inhibition of human dyskerin as a new approach to target ribosome biogenesis.

Authors:  Laura Rocchi; Arménio J M Barbosa; Carmine Onofrillo; Alberto Del Rio; Lorenzo Montanaro
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.